- STAT+: Prime Medicine claims victory in dispute over gene-editing technology with Beam TherapeuticsPrime Medicine said it had won an arbitration dispute against Beam Therapeutics, a clash that had pitted two well-backed gene-editing companies against each other.STAT · 20d ago↗ source
- STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and moreThe FDA approved a kidney disease drug from Vera Therapeutics called Trutakna, to treat IgA nephropathySTAT · 20d ago↗ source
- Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversalAn arbitration panel ruled Prime didn’t breach a deal with Beam by developing a rare disease treatment. Elsewhere, European regulators are using a pancreatic cancer drug to test a new framework for…